Reviewing NewGenIvf Group (NASDAQ:NIVF) and Avantor (NYSE:AVTR)

Avantor (NYSE:AVTR) and NewGenIvf Group (NASDAQ:NIVF) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, risk, profitability, valuation, dividends, institutional ownership and analyst recommendations.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Avantor and NewGenIvf Group, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avantor	3	10	3	0	2.00
NewGenIvf Group	1	0	0	0	1.00

Avantor presently has a consensus price target of $11.70, indicating a potential upside of 48.03%. Given Avantor’s stronger consensus rating and higher probable upside, equities research analysts plainly believe Avantor is more favorable than NewGenIvf Group.

Profitability

This table compares Avantor and NewGenIvf Group’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Avantor	-8.09%	10.45%	5.06%
NewGenIvf Group	N/A	N/A	N/A

Valuation and Earnings

This table compares Avantor and NewGenIvf Group”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avantor	$6.55 billion	0.82	-$530.20 million	($0.78)	-10.13
NewGenIvf Group	$4.73 million	0.10	$9.88 million	N/A	N/A

NewGenIvf Group has lower revenue, but higher earnings than Avantor.

Volatility & Risk

Avantor has a beta of 1, suggesting that its share price has a similar volatility profile to the S&P 500.Comparatively, NewGenIvf Group has a beta of 0.1, suggesting that its share price is 90% less volatile than the S&P 500.

Insider & Institutional Ownership

95.1% of Avantor shares are held by institutional investors. Comparatively, 66.2% of NewGenIvf Group shares are held by institutional investors. 0.3% of Avantor shares are held by insiders. Comparatively, 31.8% of NewGenIvf Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Avantor beats NewGenIvf Group on 9 of the 12 factors compared between the two stocks.

About Avantor

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

About NewGenIvf Group

NewGenIVF Group Ltd. operates as an assisted reproductive services provider. It focuses on providing fertility treatments to fulfil the dreams of building families. The firm offers in-vitro fertilization treatment service, comprising traditional IVF and egg donation, and surrogacy and ancillary caring services. The company was founded by Siu Wing Fung and Fong Hei Yue on January 16, 2019 and is headquartered in Bangkok, Thailand.